Cisen Pharmaceutical (603367.SS) Earnings Analysis
Cisen Pharmaceutical (603367.SS) has no confirmed upcoming earnings date. Trailing P/E 16.31.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 603367.SS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 603367.SS. This page updates as the calendar is published.
603367.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-09-29 | 0.3376 CNY | n/a | n/a | n/a |
| 2025-06-30 | 0.1908 CNY | n/a | n/a | n/a |
| 2025-04-21 | 0.32 CNY | n/a | n/a | n/a |
| 2024-12-31 | 0.2454 CNY | n/a | n/a | n/a |
| 2024-10-28 | 0.2823 CNY | n/a | n/a | n/a |
603367.SS valuation and analyst view
| Trailing P/E | 16.31 |
|---|---|
| Trailing EPS | 0.90215 CNY |
| Price / book | 1.06 |
| Dividend yield | 2.35% |
| Market cap | 6.47B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Cisen Pharmaceutical (603367.SS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 603367.SS. This page updates as the calendar is published.
Did 603367.SS beat earnings last quarter?
Consensus estimate data was not available for 603367.SS's 2025-09-29 report.
What is 603367.SS's current P/E ratio and EPS?
603367.SS trades at a trailing P/E of 16.31 on trailing EPS of 0.90214544459737 CNY.
What do analysts rate 603367.SS?
603367.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.